Generic Drugs News

China, traditionally known for low-end generic drugs, is now seeing its biotech firms rapidly innovate in the race to develop the next major weight-loss drug.

The market for generic Ozempic is expanding, while Mounjaro continues to maintain its premium position in the pharmaceutical industry.

While former President Trump claims credit for recent drops in U.S. prescription drug prices, experts suggest that the Biden administration's Inflation Reductio

Lupin received USFDA approval for generic Pitolisant Tablets, enhancing its US portfolio and specialty generics presence. Despite this positive regulatory news,

भारत ने अमेरिकी टैरिफ के प्रभाव को कम करने के लिए ब्रिक्स देशों में जेनेरिक दवाओं के लिए नए बाजार तलाशे हैं, जो 3.5 गुना बड़े हैं।

Former US President Trump's proposed 200% tariff on imported generic drugs, set to begin in 2028, could impact India's $9.7 billion pharmaceutical exports, thou

Health policy experts warn that proposed generic drug tariffs by Trump could increase costs and strain supplies, without guaranteeing domestic production shifts

Donald Trump has threatened a 200% tariff on generic drugs entering the United States after a two-year period of zero tariffs, which Indian pharma warns would i

Donald Trump's proposed plan to implement tariffs on generic drug imports, escalating to 200% by 2028, aims to foster US pharmaceutical manufacturing, potential

Donald Trump's proposed generic drug tariffs offer Indian drugmakers a two-year duty-free period to adjust manufacturing and supply chain strategies before sign

Donald Trump has threatened 200% tariffs on generic drugs by 2028, aiming to move manufacturing to the US, which caused a "kneejerk reaction" in Indian pharma s

The Trump administration plans to impose tariffs on generic drugs, despite having previously announced similar intentions without following through.

US President Donald Trump announced steep tariffs of up to 200% on imported generic medicines starting August 2028, a move that could significantly impact India

US President Trump has announced a phased import tariff hike of up to 200% on generic drugs, starting August 2026, which puts India's $9.7 billion exports at ri

Former President Trump announced a new 100% tariff on imported generic drugs, set to take effect from August 2028.

India is investing ₹10,000 crore in the Biopharma SHAKTI initiative to transition from generic drugs to high-value biologics. This program aims to build the nec